Ключевые слова
Как цитировать
Аннотация
Лекция посвящена различным аспектам применения внутрипросветной брахитера-пии (ВПБ) в лечении рака пищевода (РП). Дан критический обзор использования ВПБ в качестве компонента сочетанной лучевой /химиолучевой терапии в схемах неоадъ-ювантного лечения, при самостоятельной (окончательной, или дефинитивной) ХЛТ, а также в паллиативном лечении опухолей данной локализации. Суммированы разноречивые данные об эффективности брахи-терапии при местно-распространенном, неоперабельном РП. Отдельный раздел связан с перспективами включения брахитерапии в комбинированное лечение ранних форм РП. Проведенный анализ свидетельствует о необходимости стандартизации курсовых и разовых доз облучения в зависимости от показаний к ВПБ.
Библиографические ссылки
Левченко Е.В., Канаев С.В., Тюряева Е.И., Дворецкий С.Ю., Щербаков А.Г., Комаров И.В., Хандогин Н.В., Иванцов А.О., Шабатуров Л.Ю. Результаты комплексного лечения больных раком грудного отдела пищевода // Вопросы онкологии. - 2016. - Т. 62. - № 2. - С. 302-309.
Bedenne L., Michel P, Bouche О. et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 // J. Clin. Oncol. - 2007. - Vol. 25. - P. 1160-1168.
Bergquist H., Wenger U., Johnsson E. et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial // Dis Esophagus. - 2005. - Vol. 18. - № 3. - P 131-139.
Bhatt L.,Tirmazy S., Sothi S. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center // Dis Esophagus. - 2013. - Vol. 26. - № 1. - P. 57-60.
Eldeeb H, Reza S., Shmueli U. et al. External beam radiotherapy versus brachytherapy in the management of malignant oesophageal dysphagia: a retrospective study // J. BUON. - 2012. - Vol. 17. - № 3. - P. 508-511.
Fietkau R. Definitive and neoadjuvant radiochemotherapy of squamous cell carcinoma of the oesophagus // Onkol-ogie. - 2004. - Vol. 27. - P. 39-44.
Frobe A, Jones G., Jaksic B. et al. Intraluminal brachy-therapy in the management of squamous carcinoma of the esophagus // Dis Esophagus. - 2009. - Vol. 22. - № 6. - P 513-518.
Gaspar L.E., Nag S., Herskovic A., et al. American Brachy-therapy Society (ABS) consensus guidelines for brachy-therapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA // Int. J. Radiat. Oncol. Biol. Phys. - 1997. - Vol. 38. - № 1. - P 127-132.
Gaspar L.E., Qian C., Kocha W.I. A phase I/II study of external beam radiation, brachytherapy and con current chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report // Int. J. Radiat. Oncol. Biol. Phys. - 1997. - Vol. 37. - № 3. - P. 593-599.
Gaspar L.E., Winter K., Kocha et al. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report // Cancer. - 2000. - Vol. 88. - P. 988-995.
Grazziotin R., Reisner M.L., Rosa A.A. et al. HDR brachy-therapy in advanced esophageal cancer: Analysis of the palliation of dysphagia in 108 patients // J. Clin Oncology. - 2011. - Vol. 29. - № 15. - e14599.
Guedeu F., Mazeron J.-J., Ventura M. Pattern of care brachytherapy in Europe. In:Choices in advanced radiotherapy. Proceeding based on the 12th Conference Optimal use of advanced radiotherapy in multimodality oncology. - Rome, Italy, 2007. - pp. 309-317.
Gwynne S., Hurt C., Evans M. et al. Definitive chemo-radiation for oesophageal cancer- a standard of care in patients with non-metastatic oesophageal cancer // Clin. Oncol. R. Coll. Radiol. - 2011. - Vol. 23. - № 3. - P. 182-188.
Hironaka S., Ohtsu A., Boku N., Muto M. et al. Nonrandomized comparison between definitive chemoradio-therapy and radical surgery in patients with T2-3NanyM0 squamous cell carcinoma of the esophagus // Int. J. Radiat. Oncol. Biol. Phys. - 2003. - Vol. 57. - P 425-433.
Homs M.Y, Steyerberg E.W., Eijkenboom W.M. et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial // Lancet. - 2004. - Vol. 364. - P 1497-1504.
Igaki H., Kato H., Tachimori Y et al. Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection // Eur. J. Cardiothorac. Surg. - 2001. - Vol. 20. - P 1089-1094.
Kato H., Udagawa H., Togo A. et al. A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group study (JCOG9708) // Proc. Am. Soc. Clin. Oncol. - 2003. - Vol. 22. - abstr 1147.
Kato H., Sato A., Fukuda H. A Phase II Trial of Chemoradio-therapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708) // Jpn. J. Clin. Oncol. - 2009. - Vol. 39. - № 10. - 638-643.
Kapoor R., Bansal A., Kochhar R. et al. Effectiveness of Two High-dose-rate Intraluminal Brachytherapy Schedules for Symptom Palliation in Carcinoma Esophagus: A Tertiary Care Center Experience // Indian J. Palliat. Care. - 2012. - Vol. 18. - № 1. - P. 34-39.
Kranzfelder M., Schuster T., Geinitz H. et al. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer // Br. J. Surg. - 2011. - Vol. 98. - P 768-783.
Kurokawa Y, Muto M., Minashi K. et al. A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508 // Jpn. J. Clin. Oncol. - 2009. - Vol. 39. - № 10. - P. 686- 689.
Lee H.K., Vaporciyan A.A., Cox J.D. et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma:correlation with pulmonary dose-volume histogram parameters // Int. J. Radiat. Oncol. Biol. Phys. - 2003. - Vol. 57. - P 1317-1322.
Lordick F., Mariette C., Haustermans K. et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Annals of Oncology. - 2016. - Vol. 27 (Supplement 5). - P. v50-v57. - 10.1093/ annonc/mdw329. DOI: 10.1093/annonc/mdw329
Merkow R. P, Bilimoria K.Y, Keswani R. N. et al. Treatment Trends, Risk of Lymph Node Metastasis, and Outcomes for Localized Esophageal Cancer // J. Natl. Cancer Inst. - 2014. - Vol. 106. - dju133.
Minashi K., Ohtsu A., Mera K. et al. Combination of endoscopic mucosal resection and chemoradiotherapy as a nonsurgical treatments for patients with clinical stage I esophageal squamous cell carcinoma // J. Clin. Oncol. - 2007. - Vol. 25 (Suppl 18). - p. 4529.
Minsky B.D., Pajak T.F., Ginsberg R.J. et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combinedmodality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy // J. Clin. Oncol. - 2002. - Vol. 20. - P. 1167-1174.
Muijs C.T., Beukema J.C., Mul V.E. et al. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma // Radiother. Oncol. - 2012. - Vol. 102. - № 2. - P. 303-308.
Murakami Y, Kenjo M., Uno T. Results of the 1999-2001 Japanese Patterns of Care Study for Patients Receiving Definitive Radiation Therapy without Surgery for Esophageal Cancer // Jpn. J. Clin. Oncol. - 2007. - Vol. 37. - № 7. - P. 493-500.
Murakami Y, Nagata Y, Nishibuchi I. et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer // Int. J. Clin. Oncol. - 2012. - Vol. 17. - № 3. - P. 263-271.
Nemoto K., Matsumoto X. Yamakawa M. et al. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience // Int. J. Radiat. Oncol. Biol. Phys. - 2000. - Vol. 46. -№ 4. - P 921-925.
Nishio M., Horikawa Y, Morita K. et al.[The usefulness of intracavitary brachytherapy in esophageal cancer] // Gan No Rinsho. - 1988. - Vol. 34(3). - P 261-268.
Nishio M., Sakurai T, Kagami Y et al. [The dose of radiotherapy in esophageal cancer combined with external beams and intracavitary radium brachytherapy] // Gan No Rinsho, 1987. - Vol. 33. - № 3. - P. 242-248.
Noordman B.J., Shapiro J., Spaander M.C. Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol. http://www.trialregister.nl/ trialreg/admin/rctview.asp?TC=4834 (archived by Webcite at http://www.webcitation.org/6Ze7mn67B).
Polinder S., Homs M.Y, Siersema PD. et al. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer // Br. J. Cancer. - 2004. - Vol. 90. - № 11. - P. 2067-2072.
Rowland C.G., Pagliero M. Intracavitary irradiation in palliation of carcinoma of the esophagus and cardia // Lancet. - 1985. - № 2. -P. 981-983.
Sharma V., Mahantshetty U., Dinshaw K.A. et al. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy // Int. J. Radiat. Oncol. Biol. Phys. - 2002. - Vol. 52. - P. 310-315.
Stahl M., Stuschke M., Lehmann N. et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus // J. Clin. Oncol. - 2005. - Vol. 23. - P. 2310-2317.
Suh Y-G., Lee I. J., Koom W.S. High-dose Versus Stan-dard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal Cancer // Jpn. J. Clin. Oncol. - 2014. - Vol. 44. - № 6. - P. 534-540.
Sur R.K., Levin C.V., Donde B. et al. Prospective Randomized Trial of HDR Brachytherapy as a Sole Modality in Palliation of Advanced Esophageal Carcinoma - An International Atomic Energy Agency Study // Int. J. Ra-diat. Oncol. Biol. Phys. - 2002. - Vol. 53. - P. 127-133.
Takagi I. [Afterloading interstitial brachytherapy combined with external radiation and surgery in the treatment of locally far-advanced lung cancer and esophageal cancer] // Nihon Kyobu Geka Gakkai Zasshi. - 1988. - Vol. 36. - № 10. - P 2200-2212.
Teoh A.Y, Chiu P.W., Yeung W.K. et al. Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial // Ann. Oncol. - 2013. - Vol. 24. -P 165-171.
The National Comprehensive Cancer Network Guidelines in Oncology. Esophageal cancer. http://www.nccn.org. Accessed March 15, 2013.
Toita T, Ogawa K., Genki A. et al. Concurrent Chemo-radiotherapy for Squamous Cell Carcinoma of Thoracic Esophagus: Feasibility and Outcome of Large Regional Field and High-dose External Beam Boost Irradiation // Jpn. J. Clin. Oncol. - 2001. - Vol. 31. - P. 375-381.
Zhang P, Xie C.Y, Wu SX. Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer // Zhonghua Zhong Liu Za Zhi. - 2007. - Vol. 29. - № 10. - P. 773-777.
Zhou G., Chen G., Cui S. et al. External irradiation combined with intracavitary brachytherapy for esophageal cancer // Zhonghua Wai Ke Za Zhi. - 2001. - Vol. 39. - №.12. - P. 925-927.
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
© АННМО «Вопросы онкологии», Copyright (c) 2017